# Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL

> **NCT07433400** · — · RECRUITING · sponsor: **Group for Research in Adult Acute Lymphoblastic Leukemia** · enrollment: 500 (estimated)

## Conditions studied

- Ph Positive ALL

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07433400
- **Lead sponsor:** Group for Research in Adult Acute Lymphoblastic Leukemia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-29
- **Primary completion:** 2035-12-31
- **Final completion:** 2035-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433400, "Long-term Progression of Patients Treated and Monitored for Relapsed or Refractory Ph+ ALL". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07433400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*